9350912007453

Lacosamide-13C,D3

https://www.novachem.com.au/web/image/product.template/370615/image_1920?unique=b974789
SKU
L-027-1ML
UoM
1 mL
Concentration
100 ug/mL in acetonitrile
Product Brand
Cerilliant / Supelco
UNSPSC Code
41116147
Description

Lacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat®. This internal standard is suitable for lacosamide testing methods by LC/MS or GC/MS for clinical toxicology, forensic analysis, or urine drug testing.


    This combination does not exist.

    Enquire
    Share :

    (Vimpat-13C,D3)

    No Specifications

    Please note: Chemical products listed on Novachem's website are for laboratory scientific, industrial and research use only. Products are not for human use or consumption and are not available as therapeutic agents.